Loading clinical trials...
Loading clinical trials...
Discovery and Validation of Proteogenomic Biomarker Panels in a Prospective Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients - Transplant Proteogenomics
Conditions
Locations
5
United States
Mayo Clinic, Division of Nephrology
Phoenix, Arizona, United States
The Scripps Research Institute, Scripps Center for Organ and Cell Transplantation,
La Jolla, California, United States
Northwestern University, Feinberg School of Medicine, Division of Organ Transplantation
Chicago, Illinois, United States
The Cleveland Clinic
Cleveland, Ohio, United States
Medical University of South Carolina, Division of Transplant
Charleston, South Carolina, United States
Start Date
March 1, 2011
Primary Completion Date
June 1, 2016
Completion Date
June 1, 2016
Last Updated
August 14, 2017
NCT05702398
NCT07415421
NCT07006532
NCT07333495
NCT04542733
NCT06958796
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions